Promega corporation:1107424 - cell titer GLO solution
Ended Awarded
- Contract number
- HHSN31900004
- Awardee
-
Promega Corporation UEI MWM4N9L4S5X4
- Awarding agency
-
National Center for Advancing Translational Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $14,535
Award facts
- Contract value 100% obligated
- $14,535.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- Not on record
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Madison, WI 53711, USA
Award details come from SAM.gov/FPDS.
About this award
Promega Corporation received a contract award from the National Center for Advancing Translational Sciences (NCATS) for $14,535.00 to supply CellTiter-Glo Solution, a luminescent cell viability assay reagent commonly used in high-throughput screening and drug development applications. The award, issued on December 8, 2014, with an ultimate completion date of February 28, 2015, was executed as a call against Promega's existing Blanket Purchase Agreement (BPA) with the National Institutes of Health's Office of Logistics and Acquisition Operations. This BPA, valued at $10 million, establishes a framework for procurement of biological materials, chemicals, medical/scientific equipment, and maintenance services across NIH component agencies. No small business set-aside designation was applied to this contract award.
As a large life sciences manufacturer headquartered in Madison, Wisconsin, Promega supplies specialized research reagents and laboratory consumables to numerous federal agencies including NIH, CDC, FDA, and the FBI. NCATS, which focuses on translational research to bridge laboratory discoveries and clinical applications, utilizes CellTiter-Glo and similar assays in its support of biomedical research initiatives. The contract performance will take place at Promega's Madison facility, with fulfillment supporting the broader federal research infrastructure that relies on Promega's portfolio of advanced scientific technologies and diagnostic tools.
Quick answers
Who was awarded contract HHSN31900004?
HHSN31900004 was awarded to Promega Corporation by National Center for Advancing Translational Sciences (National Institutes of Health) on December 8, 2014.
How much is contract HHSN31900004 worth?
The government has obligated $14,535 on HHSN31900004.
Is contract HHSN31900004 an order under another contract?
Yes. HHSN31900004 is a BPA call under HHSN263199900051808B, a blanket purchase agreement.
Was contract HHSN31900004 competed?
The extent of competition for HHSN31900004 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award